Freely Filtered returns with another episode for NephMadness. This time we cover the hemodialysis region. ...

Nephrology Times
Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
Advertisement
Latest News
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
Researchers estimated tuberculosis incidence and described the disease among the US population with kidney failure.
A study examined whether kidney function decline accelerated after COVID-19 versus other respiratory infections.
What were the effects of moving calcimimetics from the TDAPA to an increased bundled payment?
Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D.
Is coprescription of gabapentinoids with other psychoactive medications associated with altered mental status and falls?
A study assessed the role of and patterns of multimorbidity and their association with kidney function decline.
The American Kidney Fund's Living Donor Report Card found that many US states lack protections for living kidney donors.
A new innovation center in Boston will serve as Roche's cardiovascular, renal, and metabolism research and development hub.
Furosemide (Furoscix) has been approved by the FDA for the treatment of edema in patients with chronic kidney disease (CKD).
Advertisement
Expert Interviews
Conferences
Podcasts
Freely Filtered returns with another episode for NephMadness, this time, covering the hemodialysis region.
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
Listen to the discussion of Chapter 17 of Dr. Burton Rose's book, focused on simple and mixed acid-base disorders.
Listen to part 2 of the discussion of Chapter 16 of Dr. Burton Rose's book, focused on edematous states.
Expert Columns
Ajay Singh discusses the state of rare kidney disease research.
Sarah Tolson highlights the concerns and challenges dialysis programs face under the 2025 ESRD PPS requirements.
Dr. Ajay Singh and others pay tribute to Dr. Barry Brenner, a leading nephrologist who passed away in August 2024.
Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS.
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.